To summarize the effect of Day Surgery management model for children with congenital venous malformation underwent interventional treatment.

From January 2019 to December 2019, 618 children with congenital venous malformations were treated with DSA-guided percutaneous sclerotherapy. The patients were divided into the first intervention ward (control group) and the second intervention ward (study group) by using random grouping method. The patients in the control group were given routine perioperative nursing. The patients in the study group were given day operation management nursing.

The operation was successful in all 618 patients. There were no serious complications such as ectopic embolism or limb necrosis. Adverse reaction rate was 59.87% in the control group and 63.75% in the study group with no significant difference (P > 0.05). The hospitalization costs and hospital length of stay in the study group were lower than those in the control group, and the difference was statistically significant (P < 0.01). Compared with the control group, the patient satisfaction scores were higher in the study group with significant differences (P < 0.05).

For interventional treatment of congenital venous malformations in children , the day surgery management model was safe and effective, which could shorten hospital stay, reduce hospitalization cost, and improve patient satisfaction.